The report from the University of Toronto is welcome news following all the adverse -- even hysterical -- publicity on the risks that hormone therapy may have on breast cancer. This news will be particularly important to the many women who have family histories riddled with breast cancer and who carry the BRCA1 mutation. These women often undergo preemptive surgery for ovarian cancer prophylaxsis (oophorectomy) and/or bilateral mastectomy to avoid becoming yet another breast cancer statistic in their families.
Dr. James A. Simon,
medical director of www.menopausewise.com wanted to be sure
his readers noted this press release and article. The press release is
from the Journal of Women's Health. At the end of the press release is a
link to the article.Here is the release:
John S. Wiener, MD, FAAP, FACS; Haywood Brown, MD, FACOG The decision to circumcise a newborn is best made before delivery, and the task of explaining the risks and benefits involved often falls to the ObGyn. Are you prepared to help your patients make an informed decision?
Here is the latest news from healthfinder, an award-winning Federal Web site for consumers, developed by the U.S. Department of Health and Human Services. Menopausewise.com has it! Click the links below (updated two times a week) to review the latest bulletins in these hot topics from Healthfinder.
Here is the latest news from healthfinder, an award-winning Federal Web site for consumers, developed by the U.S. Department of Health and Human Services. Menopausewise.com has it! Click the links below (updated two times a week) to review the latest bulletins in these hot topics from Healthfinder.
